Bath & Body Works’ (BBWI) Outperform Rating Reiterated at Telsey Advisory Group

Telsey Advisory Group reiterated their outperform rating on shares of Bath & Body Works (NYSE:BBWI) in a research note issued to investors on Monday morning, Marketbeat reports. They currently have a $42.00 target price on the stock. Telsey Advisory Group also issued estimates for Bath & Body Works’ Q4 2025 earnings at $2.07 EPS, FY2025 earnings at $3.28 EPS, Q2 2026 earnings at $0.45 EPS and Q3 2026 earnings at $0.59 EPS.

A number of other equities research analysts have also weighed in on the company. Morgan Stanley decreased their target price on Bath & Body Works from $51.00 to $48.00 and set an “overweight” rating for the company in a research report on Thursday, November 21st. Bank of America decreased their price objective on Bath & Body Works from $54.00 to $45.00 and set a “buy” rating for the company in a report on Thursday, August 29th. Wells Fargo & Company dropped their target price on shares of Bath & Body Works from $35.00 to $32.00 and set an “equal weight” rating on the stock in a report on Wednesday, November 6th. Robert W. Baird reduced their price target on shares of Bath & Body Works from $54.00 to $45.00 and set an “outperform” rating for the company in a report on Thursday, August 29th. Finally, The Goldman Sachs Group dropped their price objective on shares of Bath & Body Works from $60.00 to $49.00 and set a “buy” rating on the stock in a research note on Thursday, August 29th. One analyst has rated the stock with a sell rating, six have given a hold rating and nine have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $41.88.

Bath & Body Works Price Performance

Shares of BBWI opened at $35.92 on Monday. The firm has a market capitalization of $7.87 billion, a price-to-earnings ratio of 8.83, a PEG ratio of 1.14 and a beta of 1.79. Bath & Body Works has a 1-year low of $26.20 and a 1-year high of $52.99. The company has a 50-day moving average of $30.81 and a 200 day moving average of $35.65.

Bath & Body Works (NYSE:BBWI) last posted its quarterly earnings results on Wednesday, August 28th. The company reported $0.37 earnings per share for the quarter, beating the consensus estimate of $0.35 by $0.02. The firm had revenue of $1.53 billion during the quarter, compared to the consensus estimate of $1.54 billion. Bath & Body Works had a net margin of 12.43% and a negative return on equity of 44.03%. On average, equities analysts anticipate that Bath & Body Works will post 3.18 earnings per share for the current fiscal year.

Bath & Body Works Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, December 6th. Investors of record on Friday, November 22nd will be given a $0.20 dividend. This represents a $0.80 annualized dividend and a dividend yield of 2.23%. The ex-dividend date is Friday, November 22nd. Bath & Body Works’s payout ratio is 19.51%.

Insiders Place Their Bets

In other Bath & Body Works news, CEO Gina Boswell purchased 6,000 shares of Bath & Body Works stock in a transaction on Wednesday, October 9th. The stock was bought at an average cost of $29.64 per share, with a total value of $177,840.00. Following the transaction, the chief executive officer now owns 242,987 shares of the company’s stock, valued at $7,202,134.68. This represents a 2.53 % increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.27% of the stock is currently owned by insiders.

Institutional Trading of Bath & Body Works

A number of hedge funds and other institutional investors have recently made changes to their positions in BBWI. First Community Trust NA purchased a new position in shares of Bath & Body Works during the 2nd quarter valued at about $30,000. True Wealth Design LLC raised its position in Bath & Body Works by 5,270.0% during the third quarter. True Wealth Design LLC now owns 1,074 shares of the company’s stock valued at $34,000 after acquiring an additional 1,054 shares in the last quarter. Livforsakringsbolaget Skandia Omsesidigt raised its position in Bath & Body Works by 300.0% during the third quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 1,200 shares of the company’s stock valued at $38,000 after acquiring an additional 900 shares in the last quarter. Wilmington Savings Fund Society FSB purchased a new stake in Bath & Body Works in the 3rd quarter worth approximately $39,000. Finally, TD Private Client Wealth LLC boosted its position in Bath & Body Works by 24.2% in the 3rd quarter. TD Private Client Wealth LLC now owns 1,697 shares of the company’s stock worth $54,000 after purchasing an additional 331 shares in the last quarter. Institutional investors and hedge funds own 95.14% of the company’s stock.

About Bath & Body Works

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.